Related Experiment Videos
Phorbol esters inhibit low density lipoprotein processing by cultured human fibroblasts
FEBS Letters
|January 20, 1986
Summary
Protein kinase C activation by TPA significantly reduces low-density lipoprotein (LDL) uptake and degradation in human fibroblasts. This suggests protein kinase C plays a key role in regulating the LDL pathway.
Area of Science:
- Cell Biology
- Biochemistry
Background:
- Low-density lipoprotein (LDL) is crucial for cellular cholesterol transport.
- Protein kinase C (PKC) is a family of enzymes involved in signal transduction pathways.
- The regulation of LDL internalization and degradation is essential for maintaining cellular cholesterol homeostasis.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) in the regulation of low-density lipoprotein (LDL) pathway in cultured human fibroblasts.
- To determine the effect of protein kinase C activators and inhibitors on LDL internalization, binding, and degradation.
Main Methods:
- MRC5 fibroblasts were pretreated with 12-O-tetradecanoylphorbol 13-acetate (TPA), a PKC activator.
- Cells were incubated with varying concentrations and durations of TPA and other phorbol esters.
- LDL binding, internalization, and degradation assays were performed.
- The effect of PKC inhibitor alpha-cobrotoxin and non-phorbol promoter mezerein on LDL uptake was assessed.
- The effect of TPA on LDL receptor affinity was evaluated.
Main Results:
- TPA pretreatment significantly decreased LDL internalization and degradation in a dose-dependent manner, with maximal effect at 10(-7) M.
- LDL binding was reduced by 35-40%, while internalization decreased by 25% after 2 h, with longer incubation times yielding greater effects.
- Other PKC activators like phorbol 12,13-dibutyrate and mezerein also decreased LDL internalization, whereas the non-tumor promoting 4 alpha-phorbol 12,13-didecanoate had no effect.
- Alpha-cobrotoxin partially blocked TPA's inhibitory effect on LDL internalization.
- TPA did not significantly alter the LDL receptor's affinity for LDL.
Conclusions:
- Protein kinase C activation by TPA plays a significant role in inhibiting LDL internalization and degradation in human fibroblasts.
- PKC activation affects the LDL pathway by modulating LDL uptake rather than receptor binding affinity.
- These findings highlight a potential regulatory mechanism for cellular cholesterol uptake involving PKC signaling.